BrainsWay Ltd. - Enterprise Value
BWAY
Price:
$14.16
Market Cap:
$581.94M
BrainsWay Ltd. develops and distributes non-invasive neurostimulation therapies that address a broad spectrum of mental health and neurological conditions. The company operates globally, with a presence in the United States, Europe, and Israel, among other international markets. Its primary offering is the Deep Transcranial Magnetic Stimulation (dTMS) platform technology, which provides treatment for various ailments including major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post-stroke rehabilitation, and Parkinso...[Read more]
Industry
Medical - Devices
IPO Date
2019-04-17
Stock Exchange
NASDAQ
Ticker
BWAY
PE Ratio
[35.97]
ROE
[12.28%]
Current Ratio
[3.34]
Dividend Yield
[0%]
Enterprise Value
[530.01M]
Dividend History
The Enterprise Value as of July 2026 (TTM) for BrainsWay Ltd. (BWAY) is 530.01M
According to BrainsWay Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 530.01M. This represents a change of 74.84% compared to the average of 303.15M of the last 4 quarters.
BrainsWay Ltd. (BWAY) Historical Enterprise Value (quarterly & annually)
How has BWAY Enterprise Value performed in the past?
The mean historical Enterprise Value of BrainsWay Ltd. over the last ten years is 94.93M. The current 530.01M Enterprise Value has changed 55.73% with respect to the historical average. Over the past ten years (40 quarters), BWAY's Enterprise Value was at its highest in in the March 2026 quarter at 467.66M. The Enterprise Value was at its lowest in in the March 2023 quarter at -14154920.11.
Average
94.93M
Median
83.88M
Minimum
-9422483.50
Maximum
313.17M
BrainsWay Ltd. (BWAY) Enterprise Value by Quarter and Year
Discovering the peaks and valleys of BrainsWay Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 227.79%
Maximum Annual Enterprise Value = 313.17M
Minimum Annual Increase = -1150.26%
Minimum Annual Enterprise Value = -9422483.50
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 313.17M | 227.79% |
| 2024 | 95.54M | -3.46% |
| 2023 | 98.96M | -1150.26% |
| 2022 | -9422483.50 | -108.97% |
| 2021 | 105.05M | 66.31% |
| 2020 | 63.16M | -19.41% |
| 2019 | 78.37M | -12.32% |
| 2018 | 89.39M | 49.23% |
| 2017 | 59.90M | 8.53% |
| 2016 | 55.20M | -26.81% |
BrainsWay Ltd. (BWAY) Average Enterprise Value
How has BWAY Enterprise Value performed in the past?
The current Enterprise Value of BrainsWay Ltd. (BWAY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
169.23M
5-year avg
120.66M
10-year avg
94.93M
BrainsWay Ltd. (BWAY) Enterprise Value vs. Peers
How is BWAY’s Enterprise Value compared to its peers?
BrainsWay Ltd.’s Enterprise Value is greater than NeuroPace, Inc. (520.72M), greater than Delcath Systems, Inc. (359.35M), less than Tactile Systems Technology, Inc. (558.22M), less than Cerus Corporation (644.57M), greater than 908 Devices Inc. (248.71M), greater than Senseonics Holdings, Inc. (216.75M), greater than RxSight, Inc. (247.01M), greater than CVRx, Inc. (118.44M), greater than Sight Sciences, Inc. (247.35M), greater than Viemed Healthcare, Inc. (449.30M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 520.72M | $465.04M | |
| 359.35M | $399.76M | |
| 558.22M | $618.04M | |
| 644.57M | $575.06M | |
| 248.71M | $311.81M | |
| 216.75M | $203.54M | |
| 247.01M | $253.76M | |
| 118.44M | $131.35M | |
| 247.35M | $290.55M | |
| 449.30M | $446.62M |
Build a custom stock screener for BrainsWay Ltd. (BWAY) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BrainsWay Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
BrainsWay Ltd. (BWAY) and other stocks custom spreadsheet templates
The easiest way to analyze a company like BrainsWay Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Enterprise Value?
How can you use the Enterprise Value?
What is BrainsWay Ltd.'s Enterprise Value?
What is the highest Enterprise Value for BrainsWay Ltd. (BWAY)?
What is the 3-year average Enterprise Value for BrainsWay Ltd. (BWAY)?
What is the 5-year average Enterprise Value for BrainsWay Ltd. (BWAY)?
How does the current Enterprise Value for BrainsWay Ltd. (BWAY) compare to its historical average?